District leaders say the change is necessary to improve outcomes for at-risk students across all campuses. But staff, parents ...
Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal ...
Phase 1/2a study with lead Radio-DARPin MP0712 initiated; first patient dosing expected Q1 2026, initial data anticipated in 2026Full imaging and dosimetry data from MP0712 compassionate care program ...
Make sure you visit the repository hyperledger-labs/cc-tools-demo, which is a template of a functional chaincode that uses cc-tools and provides ready-to-use scripts ...
Consumers could feel an even greater squeeze in the years ahead, as utility companies predict that efforts to build data ...
CG Oncology develops cretostimogene via rolling BLA, phase 3 PIVOT-006 data in 1H 2026, and $680M cash into 2028. Find out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback